BioCentury
ARTICLE | Clinical News

Oxycodone DETERx: Phase II data

February 10, 2014 8:00 AM UTC

Top-line data from a double-blind, double-dummy, crossover, placebo- and active-controlled, U.S. Phase II trial in 36 non-dependent, recreational opioid users showed that single 40 mg doses of crushed...